|1.||Fujiki, Minoru: 7 articles (05/2010 - 09/2004)|
|2.||Kobayashi, Hidenori: 7 articles (05/2010 - 09/2004)|
|3.||Mizushima, Tohru: 6 articles (01/2013 - 04/2007)|
|4.||Abe, Tatsuya: 5 articles (05/2010 - 02/2005)|
|5.||Takahashi, Naohiko: 5 articles (12/2009 - 07/2003)|
|6.||Hoshino, Tatsuya: 4 articles (01/2013 - 06/2005)|
|7.||Ishii, Keisuke: 4 articles (05/2010 - 09/2004)|
|8.||Ooie, Tatsuhiko: 4 articles (09/2007 - 07/2003)|
|9.||Saikawa, Tetsunori: 4 articles (09/2007 - 07/2003)|
|10.||Uchida, Susumu: 4 articles (07/2006 - 02/2005)|
09/10/2004 - "Single oral dose of geranylgeranylacetone for protection against delayed neuronal death induced by transient ischemia."
09/01/2007 - "Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart."
06/01/2005 - "Oral administration of geranylgeranylacetone blunts the endothelial dysfunction induced by ischemia and reperfusion in the rat heart."
01/01/2007 - "This study was conducted to assess the effects of geranylgeranylacetone (GGA) on ischemia-induced retinal injury. "
01/01/2007 - "Neuroprotective effect of geranylgeranylacetone against ischemia-induced retinal injury."
07/01/2009 - "It has been shown that induction of HSP70 by administration of geranylgeranylacetone (GGA) leads to protection against ischemia/reperfusion injury. "
09/28/2005 - "Oral administration of geranylgeranylacetone plus local somatothermal stimulation: a simple, effective, safe and operable preconditioning combination for conferring tolerance against ischemia-reperfusion injury in rat livers."
03/02/2015 - "Geranylgeranylacetone protects against cerebral ischemia and reperfusion injury: HSP90 and eNOS phosphorylation involved."
02/01/2012 - "Geranylgeranylacetone protects against myocardial ischemia and reperfusion injury by inhibiting high-mobility group box 1 protein in rats."
06/01/2000 - "Effects of geranyl-geranyl-acetone administration before heat shock preconditioning for conferring tolerance against ischemia-reperfusion injury in rat livers."
|3.||Wounds and Injuries (Trauma)
01/01/2009 - "We planned a pilot study to investigate the protective effects of geranylgeranylacetone (GGA) against NSAID-induced small intestinal injuries using video capsule endoscopy (VCE). "
02/01/2013 - "We investigated the beneficial effects of a pharmacological treatment with geranylgeranylacetone (GGA) on keratinocytes using in vitro scratch wound injury assay in nonirradiated and irradiated conditions. "
06/01/2010 - "Geranylgeranylacetone (GGA) is known to protect the cochlea from various injuries. "
07/01/1992 - "These findings suggest that teprenone alleviates hepatocellular injuries. "
01/01/2009 - "Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study."
06/15/2015 - "Geranylgeranylacetone (GGA), an anti-ulcer drug, induces HSP70 and thereby protects against cellular damage in various diseases. "
06/01/2015 - "Geranylgeranylacetone (GGA) has been clinically used as an anti-ulcer drug. "
04/01/2015 - "Geranylgeranylacetone (GGA), an isoprenoid compound, is an anti-ulcer drug developed in Japan. "
01/01/2013 - "Since geranylgeranylacetone has already been approved for use as an anti-ulcer drug and its safety in humans has been confirmed, we propose that this drug be considered as a candidate drug for the prevention of AD. "
11/01/2011 - "Geranylgeranylacetone (GGA) has been used as an anti-ulcer drug in Japan for more than 20 years. "
01/01/2010 - "To study the effects of geranylgeranylacetone (GGA) on the expression of heat shock protein70 (HSP70) on retinal ganglion cells (RGC) in rats with chronic intraocular pressure (IOP) elevation. "
06/01/2015 - "Also, boosting of HSPs, by the heat shock factor-1 activator geranylgeranylacetone, halted AF initiation and progression in experimental cardiomyocyte and dog models for AF. "
12/08/2006 - "These reductions were prevented by HSP-inducing pretreatments: mild heat shock, geranylgeranylacetone (GGA), and transfection with human HSP27 or the phosphorylation-mimicking HSP27-DDD. "
09/01/2006 - "Hsp overexpression was accomplished by a mild heat shock or by the drug geranylgeranylacetone (GGA). "
11/01/2000 - "Induction of heat shock protein-70 (hsp-70) by intraarterial administration of geranylgeranylacetone."
|1.||HSP72 Heat-Shock Proteins
|2.||Heat-Shock Proteins (Heat-Shock Protein)
|3.||Diclofenac (SR 38)
|7.||Protein Kinase C
|9.||NF-kappa B (NF-kB)
|4.||Induced Hyperthermia (Thermotherapy)